MyoKardia Inc — Form D
MyoKardia Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-30. The offering totals $46.0M, of which $46.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-04-30
- Form: D
- Accession: 0001552451-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $46.0M
- Amount sold: $46.0M
- Investors: 9
- Date of first sale: 2015-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-238915
Issuer
- Name: MyoKardia Inc
- CIK: 0001552451
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 455 MISSION BAY BLVD SOUTH, SAN FRANCISCO, CA, 94158
- Phone: 415-766-3638
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Katherine Bowdish | Director | Waban, MA |
| Tassos Anastasios Gianakakos | Director | South San Francisco, CA |
| Charles Homcy | Director | San Francisco, CA |
| MARK PERRY | Director | SANTA MONICA, CA |
| Kevin Starr | Director | Cambridge, MA |
| Tassos Anastasios Gianakakos | Executive Officer | South San Francisco, CA |
| Charles Homcy | Executive Officer | San Francisco, CA |
Other filings by this issuer (4)
More